Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Jesus H. Dominguez"'
Publikováno v:
The Scientific World Journal, Vol 1, Pp 86-86 (2001)
Externí odkaz:
https://doaj.org/article/e6ee36f57cd34a6abf2b013cea667205
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286543 (2023)
Mortality in acute kidney injury (AKI) patients remains very high, although very important advances in understanding the pathophysiology and in diagnosis and supportive care have been made. Most commonly, adverse outcomes are related to extra-renal o
Externí odkaz:
https://doaj.org/article/85bcccc1031641108917e1d90cb21e26
Publikováno v:
American journal of physiology. Renal physiology. 323(5)
Ischemic acute kidney injury is common, deadly, and accelerates the progression of chronic kidney disease, yet has no specific therapy. After ischemia, reperfusion is patchy with early and persistent impairment in regional renal blood flow and cellul
Publikováno v:
American Journal of Physiology-Renal Physiology. 324:F64-F74
Mortality in acute kidney injury (AKI) remains very high, yet the cause of death is often failure of extrarenal organs. We and others have demonstrated remote organ dysfunction after renal ischemia. The term "cardiorenal syndrome" was first applied t
Publikováno v:
PLoS ONE, Vol 13, Iss 8, p e0202550 (2018)
Hypoxic acute kidney injury, a major unresolved problem, initiates, or aggravates, renal functional and structural decline. There is no treatment for hypoxic acute renal injury and its sequelae. We tested the hypothesis that human kidney tubular cell
Autor:
Yunlong Liu, Jesus H. Dominguez, James M Dominguez, Hongyu Gao, Danhui Xie, Katherine J. Kelly
Ischemic renal injury is a complex syndrome; multiple cellular abnormalities cause accelerating cycles of inflammation, cellular damage, and sustained local ischemia. There is no single therapy that effectively resolves the renal damage after ischemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f757ef58add8b868501f8c320aff7e8d
https://europepmc.org/articles/PMC5698065/
https://europepmc.org/articles/PMC5698065/
Autor:
Richard G. Peterson, Alan H. Roth, Jesus H. Dominguez, William A. White, Constance J. Temm, C. Subah Packer, Tomalyn Johnson, Ami E. Rice, George V. Potter, Nancy Pelaez
Publikováno v:
The Open Hypertension Journal. 6:20-26
Oxidized low-density lipoprotein cholesterol (OX-LDL), a reactive oxidant, forms when reactive oxygen species interact with LDL. Elevated OX-LDL may contribute to high blood pressure associated with diseases such as diabetes and obesity. The current
Autor:
Katherine J. Kelly, Jesus H. Dominguez, Mingsheng Wang, Ling Han, Jizhong Zhang, Shaobo Zhang
Publikováno v:
American Journal of Physiology-Renal Physiology. 305:F1804-F1812
Diabetic nephropathy, the most common cause of progressive chronic renal failure and end-stage renal disease, has now reached global proportions. The only means to rescue diabetic patients on dialysis is renal transplantation, a very effective therap
Autor:
Jesus H. Dominguez, Katherine J. Kelly, Yunlong Liu, Hai Lin, Chirayu P. Goswami, Jizhong Zhang
Publikováno v:
Physiological Genomics. 45:710-719
Despite advances in the treatment of diabetic nephropathy (DN), currently available therapies have not prevented the epidemic of progressive chronic kidney disease (CKD). The morbidity of CKD, and the inexorable increase in the prevalence of end-stag
Publikováno v:
American Journal of Physiology-Renal Physiology. 303:F357-F365
Acute kidney injury (AKI) and chronic renal failure (CKD) are the most challenging problems in nephrology. Multiple therapies have been attempted but these interventions have minimal effects on the eventual outcomes, and all too often the result is e